Unibio USA ApS: Financial statements 2025
CVR: 38179845
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Unibio USA ApS (CVR 38179845) has filed annual accounts for 2025. In 2025, the company reported a net result of DKK -20,000 compared with DKK -26,000 the year before. Equity in the 2025 report amounted to DKK 25,000. The solvency ratio was 27.8%.
- Profit/Loss
- DKK -20,000
- Equity
- DKK 25,000
- Total Assets
- DKK 90,000
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | - | -20K | 25K | 0 |
| 2024 | - | - | -26K | 45K | - |
| 2023 | - | - | -17K | 71K | - |
| 2022 | - | -18K | -34K | 88K | 0 |
| 2021 | - | -15K | -12K | 72K | 0 |
Official annual report
How creditworthy is Unibio USA ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Unibio USA ApS has published its annual report for 2024. The net result was DKK -26,000.
About Unibio USA ApS
Unibio USA ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of David Richard Henstrom and Søren Olrik Eklund. The company is owned by UNIBIO A/S. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a net result of DKK -20,000 compared with DKK -26,000 the year before. Equity in the 2025 report amounted to DKK 25,000.